Serum tenascin-C predicts severity and outcome of acute intracerebral hemorrhage

An increase in serum tenascin-C level is associated with an adverse outcome in ICH patients, supporting the potential role of serum tenascin-C as a prognostic biomarker for hemorrhagic stroke.